Goldman Sachs Group Inc.’s $500 million bet on Texas is poised to put a stamp on the Dallas skyline. The storied investment ...

This week witnesses earnings releases from giants like NVDA, DELL and BABA. Stay updated with Wall Street Week Ahead by Seeking Alpha!

Discover BJ's Q2 2025 highlights: 2.3% sales growth, 8M members, 34% digital rise. Solid earnings guidance amid macro risks.

Jefferies raised aTyr Pharma, Inc. (ATYR) price target from $9 to $17. Jefferies analyst Roger Song maintained a Buy rating.